Yan Blake Liu, M.D., MBA, joined BeiGene in March 2021 as Executive Director of the newly formed Clinical Business Development Insights (CBDi) group. Dr. Liu, a trained cardiologist from Beijing, brings nearly 20 years of experience in the U.S. biotech/pharmaceutical industry to BeiGene. His roles prior to joining BeiGene include Competitive Intelligence (CI) Lead for Hematology (including CAR-T) and Immuno-Oncology at Novartis; CI Lead for Opdivo in Melanoma, RCC and Lung at BMS; and Marketing Director, Cardiometabolic, at Quest Diagnostics. Dr. Liu leads the CBDi function to support Clinical Development in building BeiGene’s pipeline, enhancing business development opportunity search capabilities from external innovations, and assisting in the development of corporate strategy. Dr. Liu holds an M.D. from China Medical School and an MBA from the University of Maryland, College Park.